在中风患者中直接口服抗凝剂度和坚持度
Rachel Aakerøy1,2, Mari Nordbø Gynnild3,4,5, Lena Løfblad6
1Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Basic & clinical pharmacology & toxicology
|October 16, 2023
概括
与对照组相比,患有缺血性中风的患者的直接口服抗凝剂 (DOAC) 水平较低. 较高的DOAC度可能有利于脑血管风险增加的患者.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 临床化学 临床化学
背景情况:
- 对于像阿皮克萨班和里瓦罗克萨班这样的直接口服抗凝剂 (DOAC) 的治疗范围尚未确定.
- 了解与临床事件相关的DOAC度对于优化治疗至关重要.
研究的目的:
- 为了比较患有中风症状的住院患者的DOAC血清度.
- 为了区分证实缺血性脑血管事件和对照组之间的DOAC水平.
主要方法:
- 在急性事件发生后24小时内,对102名患者测量了DOACs的血清度.
- 超高性能液态色谱与双重质谱学被用于精确的量化.
- 为了进行比较,DOAC度被标准化为最低水平.
主要成果:
- 经过验证的缺血性脑血管事件的患者的DOAC度比对照组低 (255 ± 155 nmol/L) (329 ± 144 nmol/L; p=0.029).
- 没有观察到群体之间自我报告的坚持或每日剂量的显著差异.
- 在缺血性中风组中,CHA2DS2-VASc得分显著更高,这表明脑血管风险更高.
结论:
- 缺血性中风患者的低DOAC水平表明度和事件发生之间存在潜在联系.
- 较高的DOAC度可能对脑血管风险较高的患者有益.
- 需要进一步的研究来确定不同患者群体的治疗DOAC范围.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
537
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
537


